New noninvasive medical devices being developed by RespiTrend, Inc., to monitor blood propofol and blood glucose levels.
RespiTrend, Inc., announces it has secured exclusive patent and related rights for two technologies which have the potential to make a major impact on ...
Satisfied Users & 
Approved Press Releases
